The findings of the present study regarding the correlation of CRP with leptin in overweight/obese patients with HF, DM and/or MS, and the lack of gender differences in the levels of leptin may indicate the potential effectiveness of concurrent use of these biomarkers in prognosis and designing of weight-loss interventions to affect clinical outcomes in this patient population. Here, LEP is linked to myeloid sarcoma.